
Treatment of HR-positive Her2-negative advanced breast cancer
Study design, with clearly defined demographics and outcomes, facilitates decision-making
3 COMENTÁRIOSStudy design, with clearly defined demographics and outcomes, facilitates decision-making
3 COMENTÁRIOSThe Catcher in the Rye
5 COMENTÁRIOSThe ebb and flow of adjuvant trials
0 COMENTÁRIOSInterim analysis of the CheckMate 577 study
1 COMENTÁRIOS